Research Article
Efficacy and Safety of Drug-Eluting Bead TACE in the Treatment of Primary or Secondary Liver Cancer
Table 3
The efficacy for the patients treated with DEB-TACE (mRECIST).
| ||||||||||||||||||||||||||||||
CR: complete response; PR: partial response; SD: stable disease; PD: progressive disease; DCR: disease control rate; ORR: objective response rate. |